Literature DB >> 22990719

Neurological disorders associated with glutamic acid decarboxylase antibodies: a Brazilian series.

Maurício Fernandes1, Renato P Munhoz, Paulo Eduardo Mestrinelli Carrilho, Walter O Arruda, Paulo J Lorenzoni, Rosana H Scola, Lineu César Werneck, Hélio A G Teive.   

Abstract

Neurological disorders associated with glutamic acid decarboxylase (GAD) antibodies are rare pleomorphic diseases of uncertain cause, of which stiff-person syndrome (SPS) is the best-known. Here, we described nine consecutive cases of neurological disorders associated with anti-GAD, including nine patients with SPS and three cases with cerebellar ataxia. Additionally, four had hypothyroidism, three epilepsy, two diabetes mellitus and two axial myoclonus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990719     DOI: 10.1590/s0004-282x2012000900002

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  4 in total

Review 1.  Clinical Spectrum of Stiff Person Syndrome: A Review of Recent Reports.

Authors:  Harini Sarva; Andres Deik; Aman Ullah; William L Severt
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-03-04

2.  Anti-glutamic acid decarboxylase antibody (GAD) syndromes may have more aggressive disease course in African Americans and early onset of presentation compare to Caucasians group.

Authors:  Shitiz Sriwastava; Meghana Srinivas; Anila Kanna; Kalyan Yarraguntla; Abbas Jowkar; Edwin George
Journal:  eNeurologicalSci       Date:  2019-09-11

3.  Advances in Nutritional Epigenetics-A Fresh Perspective for an Old Idea. Lessons Learned, Limitations, and Future Directions.

Authors:  Lynda Sedley
Journal:  Epigenet Insights       Date:  2020-12-18

4.  Conjoint glutamic acid decarboxylase 65 and P/Q voltage gated calcium channel antibodies in autoimmune epilepsy: A case report.

Authors:  Mohamed AlKhaja; Ammar AlKawi; Mahmoud Abu-Ata; Asma Mohammaddin
Journal:  Epilepsy Behav Case Rep       Date:  2017-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.